| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:25 | NurExone rückt auf der JPM Healthcare Week 2026 als innovativer Biotech-Akteur in den Fokus | Small- & Micro Cap Investment | |||
| 21:10 | Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference | 212 | GlobeNewswire (Europe) | Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| AMGEN | 278,95 | 8,18 | +2,93 % | 2,52 | 13.02.2026 | |
| RECORDATI | 48,180 | 1,30 | +2,70 % | 0,63 | 24.11.2025 | |
| BIO-TECHNE | 56,50 | 0,27 | +0,48 % | 0,08 | 17.11.2025 | |
| REGENERON PHARMACEUTICALS | 680,20 | 3,04 | +0,45 % | 0,88 | 20.11.2025 | |
| BIOGEN | 161,20 | 0,00 | 0,00 % | |||
| ENZO BIOCHEM | 0,388 | 0,00 | 0,00 % | |||
| MYRIAD GENETICS | 5,750 | 0,00 | 0,00 % | |||
| TRANSGENE | 1,010 | 0,00 | 0,00 % | |||
| INOVIO PHARMACEUTICALS | 1,350 | 0,00 | 0,00 % | |||
| INTEGRA LIFESCIENCES | 11,700 | 0,00 | 0,00 % |